Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

AstraZeneca1,210 enrolled

Overview

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

Study Type

OBSERVATIONAL

Enrollment

1,210

Conditions

Asthma

Eligibility

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Established persistent asthma * Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer Exclusion Criteria: * Currently participating or have participated in a study with an investigational compound within the last 30 days * Current diagnosis of chronic obstructive pulmonary disease (COPD) * Smoked more than 10 packs a year

Locations (26)

Research Site

Amnat Charoen, Thailand

Research Site

Buriram, Thailand

Outcomes

Primary Outcomes

Asthma control test

Time frame: On the survey date

Secondary Outcomes

Asthma control in mild, moderate and severe persistent asthma patients

Time frame: On the survey date

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.